Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05781685 · ClinicalTrials.gov registry record · Early Phase 1
The Influence of Testosterone on Experimental Pain Perception
A Early Phase 1 study of Acute Pain, sponsored by University of New Mexi.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05781685: Completed Early Phase 1 study of Acute Pain, sponsored by University of New Mexi.
NCT05781685 is a Early Phase 1 study of Acute Pain that has completed, run by University of New Mexi. The registered enrollment target is 20 participants, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05781685, a Early Phase 1 study of Acute Pain, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).
Primary Outcome
The ischemic discomfort task applied a sphygmomanometer (blood pressure cuff) 5 cm below their elbow. The cuff was inflated to 200 mmHg. Pain tolerance was measured by how long they could tolerate the ischemic discomfort task. However, task was only allowed to last for 6 minutes
Conditions Studied
Interventions
- DRUG Testosterone
- OTHER Placebo Syrup
Study Locations (1)
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-10-01 |
| Est. Completion | 2018-07-17 |
| Phase | Early Phase 1 |
What the finished NCT05781685 record still lists
NCT05781685 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 268-participant average among 50 other Acute Pain trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 2 interventions - of which Testosterone is the first listed.
NCT05781685 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT05781685 about?
NCT05781685 is a clinical study titled "The Influence of Testosterone on Experimental Pain Perception". This trial examined how the administration of exogenous testosterone would influence pain tolerance and other endogenous steroids (i.e. estradiol and progesterone).
What is the current status of trial NCT05781685?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2017-10-01. Estimated completion is 2018-07-17.
What conditions does trial NCT05781685 study?
This clinical trial studies the following conditions: Acute Pain.
What interventions are being tested in trial NCT05781685?
The interventions under investigation include: Testosterone (DRUG), Placebo Syrup (OTHER).
Who is sponsoring clinical trial NCT05781685?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05781685 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05781685's enrollment target sits among peer trials
20 48th of 50 higher than 1 of 50 other Acute Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures
COMPLETED · Early Phase 1
-
Characterization of Acute Pain
RECRUITING
-
Understanding the Acute Pain Phenotype in Patients Undergoing Surgery
RECRUITING
-
Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
RECRUITING
-
Reducing Pain From Wisdom Molar Extractions
RECRUITING · Phase 2
-
Twin Block, Pain Medications and Third Molar Extractions
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI